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ABSTRACT 
The range of pathologies that Lymph Node (LN) Fine-Needle Cytology (FNC) may deal 
with is extremely wide and ancillary techniques, in addition to traditional smears, are 
generally required to reach reliable cytological diagnoses. For this purpose, in the pre-
analytical phase of LN-FNC, using the most effective vials, fixatives and supports is 
essential, since they may perform differently with different ancillary techniques, and even 
in different pathologies. Moreover, storing part of the cytological material may be useful or 
necessary for molecular testing. The main difficulties concern the generally small size of 
the sample and the different ways of acquisition of LN-FNC. Therefore, the pre-analytical 
phase is extremely important for LN-FNC. This study investigates the management of LN-
FNC material, vials, technical supports and main ancillary techniques in order to assess 
their optimal application, taking into account the different diagnostic needs and cell 
storage.  
 
Key words: Lymph Node Fine-Needle Cytology, cell block, cytospin, liquid based cytology, 
flow-cytometry, cell storage. 
 
INTRODUCTION 
Lymph Node (LN) Fine-Needle Cytology (FNC) may be performed in different clinical set-
tings with different diagnostic needs; it can be performed in different anatomical sites and 
even at different times on the same patient. LN-FNC can be guided in different ways, in-
cluding palpation, ultrasound (US), computed tomography (CT) and esophageal ultra-
sound-endobronchial ultrasound (EUS-EBUS). The above factors may affect the quantity 
and quality of cell yielding. The range of pathologies that LN-FNC may deal with is wide 
and ancillary techniques, in addition to traditional smears, may be required to reach a final 
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diagnosis. However, to obtain consistent and accurate immunocytochemistry (ICC), fluo-
rescence in-situ hybridization (FISH), flow cytometry (FC) or molecular results, using the 
most effective vials, fixatives and supports is essential, since they may perform differently 
with different ancillary techniques, and even in different pathologies. These difficulties may 
be further enhanced by the generally small size of the sample and the different ways of 
acquisition of the cytological sample. Therefore, an accurate control and standardization of 
all the variables affecting the pre-analytical phase of LN-FNC is mandatory. It is also es-
sential to standardize procedures and diagnostic algorithms in the clinical practice to max-
imize the potential information of each technique.1 Therefore, ancillary techniques, vials 
and supports have to be chosen on the basis of the specific pathologies, diagnostic needs 
and characteristics of the yielded material. LN-FNC should ideally provide cells to be 
stored for further investigations, specifically for molecular testing. Considering these fac-
tors, LN-FNC requires a specific approach that is quite different from the one used for FNC 
of any other organ or pathology. Moreover, the amount of material obtained by FNC is lim-
ited by definition and, therefore, it has to be exploited to the most by transferring such ma-
terial into vials or any other support that better matches with the selected ancillary tech-
nique. For this purpose, FNC should be performed by a cytopathologist with rapid on-site 
evaluation (ROSE) for the optimal management of the diagnostic material and overall for 
an effective LN-FNC.2,3 The main supports and vials used for LN-FNC are air-dried or al-
cohol-fixed smears, buffered mediums (PBS, Cytolyt, RNA-later, etc.) and formalin.4-10 The 
most frequently used ancillary techniques are FC11-20, ICC21-63, FISH64-65 and molecular 
tests.66-73  As far as cell storage is concerned, whereas genetic material can be obtained 
by any technical support, cryostorage is the best procedure to store LN-FNC cells, as well 
as different cells and tissues.74-85 Recently, special FTA cards have been used to store ge-
netic material.74-85 Each support or vial is characterized by specific features that fit with 
each of these ancillary techniques; conversely, ancillary techniques may be applied to 
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cells on several or single technical supports. Choosing one support over another is im-
portant for LN-FNC, as well as using one technique over another. The following factors 
should also be taken into account: experience of the laboratory, availability of techniques, 
quality of the obtained sample (cellularity, blood contamination), antibodies or probes to be 
used, cell targets (nuclear, membrane or cytoplasmic), presence of other cellular elements 
(residual lymphoid population, histiocytes, necrosis) and size of cells to be studied. This 
study investigates the management of LN-FNC material, vials, technical supports and 
main ancillary techniques in the main LN pathological processes, with exclusion of meta-
static lung cancer that is described in a different review of the present issue. This study al-
so aims to assess the optimal application of the above items by taking into account the dif-
ferent diagnostic needs and cell storage. Because of these differences, the application and 
performance of ancillary techniques in each of the different groups of LN pathologies is 
here described in independent sections (Fig. 1).  The main use of different technical pro-
cedure, according to the different LN pathologies,  is reported in Table 1. 
 
CELL BLOCK 
Cell Block (CB) procedures are the most used and validated methods for ancillary 
techniques, including immunostains, molecular assays and archival purposes in LN-FNC. 
Several methods can be used to set up CBs,4,5,6 which use different agents to congeal 
pellets (gelatin, plasma thrombin, agar, histogel and acrylic resin) and fixatives.4-8 Cell 
suspensions are generally fixed in formalin before being transferred to pellets, or may be 
post fixed in formalin after a previous fixation with alcohol-based fixatives, as in the case of 
Liquid Based Cytology (LBC). Other CB procedures5,7 use alcohol-fixed cells to prepare 
automatized cell-blocks4-8.  With reference to CB from LN-FNC, since they mostly originate 
from FNC and ROSE performed by cytopathologists, formalin fixation of aspirated cells is 
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generally the most used procedure4,6,9 . This is a point of standardization for LN-FNC10 
because many antibodies have been validated on formalin-fixed, paraffin-embedded 
(FFPE) histological samples, which are also the main source of material for molecular 
assays. Nonetheless, as reported above, LN-FNC can be performed in a wide range of 
pathologies, providing significant differences in terms of cell quality and quantity. This 
paragraph evaluates the advantages and limitations of CB applied to specific LN 
pathologies remembering which the different diagnostic needs may not be fully satisfied by 
a unique technical support. 
 
Reactive hyperplasia   
Reactive LNs are the most common target of LN-FNC; conventional smears, combined 
with clinical and ultrasound data, may lead to a diagnosis in a number of cases. Ancillary 
techniques may be required in case of a differential diagnosis with low-grade NHL, or 
when there is a need to “look inside” dense groups on smears and search for diagnostic 
cells in suspected Hodgkin’s cells or to exclude micro metastases, in case of a previous 
known neoplasia. In case of reactive processes with follicular expansion, the differential 
diagnosis with a follicular lymphoma (FL) is generally pointed out. This latter mainly 
depends on the quantification of cell phenotypes mainly performed by FC11-20, ICC on 
cytospins21-26 or LBC.27-30 Few large experiences are reported on CB ICC of LN reactive 
processes, claiming high sensitivity and specificity for LN-FNC of lymphoma and reactive 
processes.31-34 CB was also used for LN-FNC of specific lymphadenopathies to apply 
special stains, such as silver and Ziehl-Neelsen staining.35-37 Therefore, CB may be used 
to detect specific antigens by means of ICC when cultural examination or staining on fresh 
material cannot be performed. In the case of specific lymphadenopathies, the examination 
of CB sections prepared from tissue fragments present in the aspirated material allows to 
observe the whole morphology of the lesion because the architectural relationship of the 
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different cell types is preserved. This is the case of Kikuchi's disease38, Castleman's 
disease39 and lymphadenopathies with a granulomatous pattern.40 CB has been 
successfully used in LN-FNC of sarcoidosis and other granulomatous processes on 
superficial or deeply located LNs (mainly, mediastinal) by EUS-EBUS40. The main 
weaknesses of CBs are the scanty cellularity and the absence of tissue fragments.4,5  
 
Non-Hodgkin and Hodgkin lymphoma 
CB may be used in the LN-FNC diagnosis of NHL as support for ICC and molecular 
procedures.10,41,42-44 ICC on NHL aims to identify the phenotype of the cell population, the 
possible expression of aberrant antigens, the light chain assessment and the evaluation of 
proliferative index. For these purposes, FC and ICC on cytospins are usually used more 
often in comparison to CB, especially when dealing with small or medium sized cell NHL11-
20
. ICC on CB may be effective mainly in high grade NHL, in which nuclear atypia mainly 
stands for malignancy and ICC can identify the specific phenotype even on samples with a 
limited amount of material. This point was assessed by Mayall et al.41, who used ICC on 
CB and FC to diagnose a series of HL and NHL. These authors concluded that FC is less 
useful than CB-ICC for T-cell NHL and HL. In their experience, CB was preferred for HL, T-
cell NHL and other large-cell NHL in which the differential diagnosis with non-
lymphomatous malignancies was pointed out. This point was assessed by NG et al45 who 
used CB for ICC of anaplastic large cell lymphoma (ALCL) using a specific panel of 
antibodies; it was further supported by Rapkiewicz et al.46 Only one study47 has been 
performed on a large series of LN- and extra-nodal-FNC that included either small and 
large cell NHL and HL, using CB as technical support. These authors reported high 
accuracy (86,6%; 84/87 cases) in the diagnosis and classification of NHL, comparable to 
the one generally reported for FC NHL.11-20 CB has also been successfully used in the 
FNC diagnosis of “malignant lymphoma, large B-cell type” and leukemia involving soft 
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tissues48 and in extra-nodal NHL of the breast49,50 and other sites.51-56 CB has been also 
used for the sub-classification of DLBCL in GC and non-GC type by ICC, using a limited 
number of antibodies, such as CD10-BCL6-MUM1.33 More recently, CB has been 
successfully used, together with other technical supports, in a large series of LN-FNC of 
Mantle cell Lymphoma (MCL) for SOX11 evaluation, showing a strong positivity in all 
cases and correspondence to the histological controls.26 Das et al.57 used different series 
of antibodies on CB to differentiate T-cell prolymphocytic leukemia (T-PLL) with 
overlapping cytomorphological features from T-CLL and T-ALL. Lynnhtun et al.58 performed 
a similar study on unclassifiable, B-cell NHL, with intermediate features between DLBCL 
and HL. Finally, single case reports have described specific entities such as follicular 
dendritic-cell tumors (FDCT)59, nodal presentation of nasal-type NK/T-cell lymphoma60 and 
others using specific antibodies on CB. As reported above, CB is a valid support for ICC, 
and it may also provide information about the “micro-histology”. For instance, Ng et al.61 
described the “cyto-microhistological details” of the angioimmunoblastic T-cell lymphoma 
using direct smears, cytospins and CB sections. In these latter, the intimate admixture of 
small lymphocytes, plasma cells, eosinophils and reticulum cells with reticular fibers could 
be detected, becoming the key point of the diagnosis61. Therefore, dense groups that 
represent a limitation on the smears are turned into a diagnostic key on CB. This is also 
the case of LN-FNC of angioimmunoblastic hyperplasia, where smears are poorly cellular 
and dense groups do not allow cell identification. Conversely, CB sections in the same 
fragments showed “burned out” follicles, vascular structures, fibroblasts and atypical 
cells.62 FISH is widely used on cytological samples of different neoplasms, including 
NHL.63 Direct smears and cytospins are generally preferred for FISH using dedicated or 
even destained slides, probably because of the nuclear integrity of these samples. CB has 
been used for FISH identification of the IGH-BCL2 and c-MYC rearrangement in the 
“double-hit” NHL.42 With reference to molecular testing, CB has been rarely used for 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
specific tests such as IGH or TCR rearrangements, probably because of the scanty 
amount of DNA that could be obtained; IGH or TCR rearrangements were usually 
performed on the residual material of cell suspensions. 64,65 
 
Metastases 
LN-FNC of metastases is generally performed for cancer staging, identification of unknown 
primary tumors and for prognostic-predictive information. With reference to tumor staging, 
conventional smears usually meet diagnostic needs; conversely, unknown primary tumors 
and prognostic-predictive information require ICC or specific molecular tests. LN-FNC of 
most non-lymphomatous tumors generally yields cell fragments rather than isolated cells 
that are more suitable for embedding and CB preparation. Moreover, ICC on “FFPE cells” 
perfectly matches standardized protocols of IHC. Consequently, CB is the most used 
technical support for LN-FNC metastases. 
 
Head and Neck 
FNC is often the first diagnostic procedure performed in patients with head and neck 
(H&N) masses. In case of squamous cell carcinoma (SCC), proper management and 
prognostic evaluation depends on the site and size of the primary tumor and on possible 
Human Papilloma Virus (HPV) correlation. Knowing the HPV status of metastatic H&N-
SCC has significant implications in terms of treatment and prognostic evaluation therefore 
HPV testing should be performed on any SCC identified in H&N-LN.66 HPV detection may 
be performed using p16 or ProExC as a surrogate IHC marker, in-situ hybridization (ISH), 
PCR detection of HPV DNA or RNA. Hou et al.67, demonstrated that, in a series of 87 cer-
vical LN-FNC, CB material was adequate in most of the cases for reliable HR-HPV testing 
with adequacy rates of 86% for HR-HPV by ISH and 93% for p16 by IHC in 84% for both 
procedures and in 95% for either one. These data are consistent with previous studies.68-70 
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Laleh Hakima71 used p16 on CB and hybrid capture 2 (HC2) for HPV on needle rinse ma-
terial of LN-FNC to determine HPV status in H&N-SCC. In addition to HPV, EBV status, 
mainly on poorly differentiated SCC, may be useful to identify metastatic nasopharyngeal 
carcinoma. Jannapureddy et al.72 successfully examined a series of cervical LN-FNC with 
metastatic SCC to perform HR HPV types (6,18,31,33,51) by ISH, p16 and ProExC (by 
IHC), and EBV (EBER by ISH), HPV and EBV (EBER by ISH) in an attempt to determine 
the primary site of origin of the metastatic SCC.  
 
Breast 
Axillary LN status is a crucial point in the management of breast cancer (BC), in either 
preoperative assessment or follow-up. Surgical excision and histological evaluation is the 
gold standard for axillary LN status, but it is not free from possible complications, including 
lymphedema and loss of sensitivity. Core biopsy has largely replaced FNC of breast 
lesions in many Institutions, but it has relevant limitations on LN of this anatomical area. 
Therefore, in the last decades, FNC has regained a role in LN assessment in BC patients. 
Direct smears are generally sufficient to meet the main diagnostic need (positive/negative). 
Nonetheless, by combining smears and CB, Engohan-Alogheet al.85 obtained a specificity 
of 100% vs. 14% for axillary US evaluation alone, and sensitivity was at 73% for axillary 
CB and 87% for axillary US in a series of axillary LN-FNC in preoperative staging. Similar 
results were obtained in BC follow-up by means of LN-FNC BC.86 In advanced cases or in 
follow-up, when ER-PR, Her2-neu assessment is requested, formalin fixed cells and CB 
are valid supports because they reproduce the technical conditions of the histological 
samples. Nakayama et al.87 found out a high concordance between LN-FNC-CB and the 
primary tumors in the assessment of ER-PR status and HER2 expression in 20 metastatic 
(8 synchronous and 12 metachronous) BC on LN-FNC (10 cases) and effusions (10 
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cases). Briffod et al.88 assessed the reliability of ER-PR, p53, HER2-neu and MIB-1 by ICC 
on CB obtained from diagnostic FNC of BC and LN metastases. A good correlation was 
observed between ICC on CB and on the corresponding tumors and, therefore, in this 
study, an excellent correlation can be observed between CB results for primary tumors and 
LN metastases.  
 
Melanoma 
LN-FNC is an accurate method for the diagnosis of metastatic melanoma and for the 
follow up protocol of high-risk melanoma patients. In up to 20% of cases, LN metastases 
and subsequently FNC diagnosis of metastatic melanoma are the first clinical 
manifestation of the disease, without a known primary lesion.89,90 In these cases, due to 
the high variability of cytological presentation, morphology alone may not be sufficient for a 
proper diagnosis, even in patients with a known history of melanoma, thus expanding the 
differential diagnosis. In these cases, the use of ancillary techniques enables the diagnosis 
and facilitates patient management90(Fig. 2). Moreover, as constitutively activating 
mutations in the BRAF oncogene are present in at least 40% of melanomas, patients with 
advanced-stage melanoma harboring a BRAF mutation are candidates for BRAF inhibition 
as therapeutic strategy and FNC material can be used to evaluate the BRAF mutational 
status. In the few studies dealing with LN-FNC of metastatic melanoma, DNA was purified 
from Diff-Quik stained direct smears.91,92 For this purpose, CB material is a valid technical 
support for ICC studies and to perform ancillary molecular tests that can provide useful 
insights and targeted chemotherapeutic options. 
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CYTOSPINS AND LIQUID BASED CYTOLOGY 
Cytospins and liquid-based cytology (LBC) techniques concentrate cells from a cytological 
suspension. Slides can be used for routine staining and for several other proposes: ICC, 
histochemical, and molecular techniques (FISH and PCR based procedures, including 
High Throughput Technologies (HTT)/ Next Generation Sequencing (NGS). Thin Prep 
(Hologic Inc, Marlborough, Massachusetts) and BD SurePath™ (Becton Dickinson, Frank-
lin Lakes, New Jersey) are the two most common liquid-based methods approved by the 
U.S. Food and Drug Administration (FDA) for processing cytological samples and for mo-
lecular tests. The first goal of cytospins and LBC slides is to provide a monolayer prepara-
tion with well-preserved cellular detail, removing the background (blood, debris 
immunoglobulins), allowing an accurate cytological diagnosis and a reliable high-quality 
sample for ancillary techniques. In LN-FNC the needle can be rinsed for cytospin prepara-
tion in a 500 µl serum and/or albumin based suspension (PBS, Phosphate Buffered saline 
or RPMI, Roswell Park Memorial Institute) or, in the case of ThinPrep or SurePath, in a 
CytoLyt or CytoRich solution, respectively. The best medium for cell suspension is the one 
that delays cell death and protects cells during the slide preparation process. PBS and 
RPMI provide a pH balanced liquid and ion replacement to mimic the cell’s native envi-
ronment; however they are not fixative solutions and the sample requires to be quickly 
processed. Sample collection in unbuffered physiological saline solution (0.9% NaCl) 
should be avoided. ThinPrep (a methanol-water solution) and SurePath (an ethanlol-
formaldehyde solution) are both fixatives. Cytospin technique is a centrifugation technique 
through which cell suspensions are spun onto a microscope slide by centrifugal force. The 
fluid from the suspension is absorbed onto filter paper while the centrifuge is spinning and 
blood proteins, immunoglobulins and cell debris are absorbed, providing clean and 
monolayered samples for ICC and FISH. Several slides can be prepared, based on the 
cellularity of the sample. Cytospin slides can be fixed and stored in several ways; they can 
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be placed in coated slides to prevent cells from peeling while ICC is performed; they can 
be air-dried overnight and ICC can be performed the next morning; they can be immedi-
ately fixed in alcohol 95% and stained in Giemsa, Hematoxylin-Eosin (H&E) or 
Papanicolaou method; after being stained, they can also be reused for ICC. Moreover, 
slides can also be freezed for 3 months at -20°C to -80°C, after being fixed in acetone for 
10 minutes, and then reused for ICC. In the BD SurePath™ method, the sample is 
vortexed, strained, layered onto a density gradient, and centrifuged. In the ThinPrep-
Hologic method, cells are collected on the surface of the filter when a vacuum is applied. 
The filter is then pressed against a slide to transfer cells into a 20-mm diameter circle. 
Both methods result in a well-preserved monolayer of cells, with a background with no 
blood and mucus. The vial can be kept for 3 months and it can be used for the preparation 
of more slides, CB, and for DNA or RNA extraction for molecular tests. Some studies re-
port longer stability of DNA in both methods when stored at 2 to 8°C.93  In cytospin and 
LBC, ICC can be performed directly on unstained or destained slides or on additional 
slides from the remaining vial. The main disadvantage is that cytospin and LBC do not al-
low a simultaneous assessment of multiple markers on the same cells, as FC does. Now-
adays, FISH and high throughput techniques (HTT) have a key role in detecting specific 
molecular alterations and FNC is an excellent option for DNA and RNA extraction required 
for molecular techniques.94,95  FISH and HTT can be performed in cytospins or LBC, pro-
vided that the sample meets the minimum requirements of cellularity and tumor fraction 
(10% to 20% of the sample).96  Roy-Chowdhury et al97 demonstrated the high quality DNA 
and RNA obtained from cytospins is suitable for PCR techniques, even if extracted from 
stained cytospins or LBC. Although some authors report that ethanol fixation results in a 
better DNA quality in comparison to air drying, it seems that both options do not greatly af-
fect the quality of genetic material and the results of next generation sequencing (NGS) 
techniques.98,99 Studies indicate that ThinPrep, methanol-liquid based fixation, provides 
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higher quality DNA than SurePath ethanol fixative.99 Other studies compared ThinPrep 
slides and direct smears, reporting higher DNA stability in ThinPrep samples and higher 
tumor cell fraction in direct smears.99 Tumor mapping can be performed to enrich tumor 
fraction and cells can be extracted with direct scraping and cell-lifting, although the latter 
provides inferior results.97 
 
Reactive hyperplasia 
Most lymphadenopathies are due to inflammatory or infectious causes or to non-specific 
hyperplasia, which are diagnosed with the joint work of FC and ICC.100,101 Histochemical 
stains like Gram, Grocott, and Ziehl-Neelsen can also be performed in both cytospins and 
LBC to identify infectious agents. In case of a suspected granulomatous process, 
tuberculosis or sarcoidosis, CB should be preferred over LBC because granulomas do not 
adhere to ThinPrep, SurePath slides or cytospin slides. Lymphocyte immunoprofile and 
clonality can be achieved through ICC, which can be carried out either in LBC, 
cytospins102, CB, or through FC. Each method has advantages and disadvantages that 
affect the final result. 
 
Non-Hodgkin and Hodgkin Lymphoma 
The main advantages shared by cytospins and LBC are the capacity of concentrating cells 
from low cellularity samples and the possibility of multiple slides with a clean background 
that facilitates ICC and its interpretation. Good ICC results can be obtained for different 
antibodies, including kappa and lambda chain, which are mandatory in lymphoma and 
whose interpretation may be difficult in CB and smears due to the excessive background 
signal.103 Conversely, disadvantages of ICC on cytospins and LBC are the lack of 
appropriate and validated cytological controls and the limited number of slides obtained, 
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which may not be sufficient for a final diagnosis. Being aware of these limitations is 
important when dealing with LN-FNC, so that additional passes can be performed to enrich 
cell suspensions. Even when FC is available, cytospins should be prepared for those 
antibodies that are not routinely used in FC but may be useful in the differential diagnosis 
of lymphoma, like cyclin D1, CD30, CD15, PAX5, Ki67, MUM1103, or for the 
characterization of metastases. Another advantage of cytospin and LBC when compared 
to FC is the possibility to detect and immunostain large cells (large-cell NHL, Reed 
Sternberg or Hodgkin cells) that are not detected by FC or rare neoplastic cells with severe 
necrosis, such as104 Sternberg Reed cells in Hodgkin lymphoma (HL) and malignant B 
cells in T-cell rich large B-cell lymphoma. In these specific entities, morphology and ICC 
shall be assessed together to identify cells expressing specific antigens. This is the case of 
anaplastic T-cell NHL composed of large pleomorphic cells that may overlap with HL.,104-
106
  
 
Metastases 
Cytospins and LBC are excellent support for metastases. Cytospins are ideal to perform 
ICC to determine the putative primary origin, predictive factors, and to perform molecular 
techniques for targeted therapies. With reference to LN non-small cells lung cancer 
(NSCLC) metastases can be accomplished on cytospin and LBC by morphology and ICC. 
The following step is the selection of adequate material for molecular testing and 
therapeutic selection, namely for EGFR, KRAS, ROS, and ALK assessment Emergent PD-
1 and PDL-1 target therapies are being applied in several types of cancer.107-111 Recent 
works have assessed the possibility to evaluate PD-L1 expression in primary and 
metastatic NSCLC cytology samples (Cell-block), including TBNAs of mediastinal LNs, and 
FNC of peripheral LNs with reliable results.111 
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FLOW CYTOMETRY  
Flow cytometry (FC) is a powerful diagnostic tool to define cell phenotypesfrom LN-FNC.11-
20,97,115
 The application of fluorochrome labelled antibodies to cell suspensions allows a 
multi-parametric acquisition of data on individual cells by laser light detection. The ability of 
FC to provide quantitative results, including data on cell antigen profile, antigen co-
expression and light chain evaluation, as well as the possibility to detect small abnormal 
lymphocyte populations, make FC an ideal method to examine lymphoid cell population 
from FNC and fluids of all kinds.11-20 FC is a standard basic procedure in the cytological 
differential diagnosis of lymphoid reactive processes and low-grade non Hodgkin 
lymphomas (NHL).11-20,1  FC may be used for both recurrent and primary NHL on LN-FNC 
with high sensitivity and specificity for the final diagnosis.16 However, a correct indication 
for the application of FC to any FNC specific sample is crucial. Enlarged LNs with typical 
cytological features at microscopic examination in young patients (<30, and especially <20 
yrs) are mostly due to reactive processes and rarely require FC. In older patients (>50 yrs), 
due to the higher probability of NHL, FC should be performed for any lymphoid cell 
proliferation, even without morphological abnormalities. FC is indicated in case of 
unexplained, persistent or progressive LN enlargement in patients from 40 to 50 yrs, both 
with and without history of lymphoma, if the  smears does not show granulomas, Hodgkin 
cells or metastasis. FC results should be carefully examined in cases of high-grade, large 
cell and anaplastic NHL and might require further studies on direct smears or CB, since 
false negative FC results are common. In these cases, the specific binding of antibodies to 
fragile cytoplasm of neoplastic cells may be hampered by degeneration or necrosis. 
Moreover reactive cells with well-preserved antigens, may overshadow the neoplastic 
cellscausing false negative results.117-119 Cell suspension for FC should be acquired during 
LN-FNC in all cases where other causes of lymphadenopathy are excluded, and (based on 
presentation or clinical data, but preferably during and ROSE) should be performed during 
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FC procedure and analysis. Clinical data and ROSE should be performed during FC 
procedure and analysis.120 Many different fluid media can be used for the preparation of 
cell suspension for FC, including PBS, RPMI or EDTA; in all these media, cells antigens 
are stable over many hours. Since an optimal FC analysis depends on at least 10.000 and 
not less than 5000 acquired events, one or two millions cells for FC should be harvested. 
This number is easily reached in the standard LN-FNC, especially when an additional 
dedicated pass is performed for this purpose. In many cases, a well-managed single pass, 
which is performed by an experienced cytopathologist, may provide enough material to 
prepare direct smears, CB and cell suspension for FC. When LN-FNC is hampered by 
fibrosis, blood and necrosis, ROSE and or cell counting may assess the need for 
additional passes. The antibodies applied may vary according to the indication and type of 
lymphoproliferative process, the minimal set consisting of CD45, CD14, CD3, CD19, CD5, 
CD10, CD23, ƙ and ƛ chains. However, many other antibodies specific for different entities 
or for prognostic evaluation may be added.120  
 
Reactive hyperplasia 
Reactive unspecific lymphadenopathy due to immune response, inflammatory process or 
viral infection represents one of the most common indications for LN-FNC . In many cases, 
especially with young patients (i.e. < 20-30 yrs), lymphadenopathies are self-limiting,  LN-
FNC show normal lymphoid cells , and do not require further work-up. In persistent cases 
with clinical progression, especially with older patients or with a history of NHL, FC is 
indicated when ROSE excludes any granulomatous processes, Hodgkin’s lymphoma or 
metastasis.  
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Low-grade non-Hodgkin lymphoma 
When LN-FNC of suspected LNs contains monomorphous population of small lymphoid 
cells, the differential diagnosis of a low-grade NHL has to be considered. In patients with a 
history of NHL, a residual or partial LN infiltration may be present. FC is of significant 
diagnostic value in such situation, being able to provide rapid results and detecting even 
small pathologic populations, mainly in small cell, low-grade NHL.11-14 
FC is generally less effective in the cytological diagnosis of high-grade or anaplastic NHL. 
As previously reported, necrosis and cell fragility may lead to under-detection by FC and 
cause false negative results. The immunophenotyping of such cases is preferably done by 
IHC on CB or additional slides, as described above. However, some non-pleomorphic 
subtypes of aggressive NHL, such as Burkitt lymphoma, high-grade intermediate B-cell 
NHL and B-acute lymphoblastic leukemia (B-ALL) can be diagnosed by FC and this rapid 
diagnostic method is extremely useful in these clinically aggressive diseases, prior to final 
molecular studies.117-119  
 
Hodgkin lymphoma (HL) 
FC is not useful in the diagnostics of HL, except for the demonstration of reactive 
lymphatic background of the disease. If no classical Hodgkin or Reed-Sternberg cells are 
present and FC provides a reactive pattern in a pathologic LN, a differential diagnosis of 
lymphocyte predominant HL (paragranuloma) should be considered. 
 
Metastases 
Malignant epithelial cells may be detected on LN-FNC samples by FC using a combination 
of markers, including CD326 (epithelial-specific antigen, clone Ber-Ep4), CD45 (to 
discriminate between leucocytes and epithelial cells) and CD33 (to identify 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
monocytes/macrophages). In particular, the FC phenotype for epithelial cells is CD45-, 
CD33-, CD326+; may demonstrate the presence of LN metastasis.123  
 
CRYOSTORAGE AND FTA CARDS 
In the era of molecular biology and personalized medicine, the need to store genetic 
material from tissues and cells is mandatory. Direct smears, cytospins, LBC or CB are not 
primary used or intended for this purpose; therefore, after diagnostic procedures, cell 
storage may be hampered by scanty residual cellularity or by the specific technical 
characteristics of vials and supports. An optimal and effective cell storage requires specific 
cell management and technical supports. Focusing on LN-FNC, the need to store material 
is mainly related to metastases when primary tumors are not achievable or available as it 
may occur in EUS- or EBUS-FNC of mediastinal LN. In case of NHL, LN-FNC cell storage 
may be necessary for clonality testing and for DNA sequencing by NGS or HTT. The latter 
applications may be requested in LN or extra-nodal NHL when surgical biopsy cannot be 
performed, and FNC cytological material is the only one available for diagnostic or 
molecular tests. Vital cells, like those obtained by FNC, are the best sample for any 
molecular procedure because nucleic acids are preserved, or less degraded at least, when 
compared to any other storage procedure. However, even when ROSE requires molecular 
testing, the organization of the different laboratories generally does not allow direct 
processing of samples, hence cell storage is required.  
 
Cryostorage 
Cryostorage has been used for tissue and cell storage since many years; it is the best 
cryopreservation system because it keeps cell antigenicity and DNA and RNA integrity, 
thus avoiding the coagulation of proteins caused by alcohol-based fixatives and cross-links 
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between proteins and nucleic acids. Moreover, cryostorage preserves almost all the 
genetic material; on the contrary, up to 30% of nucleic acids may be lost during fixation.73  
Cryopreservation avoids fixation-related disadvantages and it is the most effective proce-
dure to store RNA. Only a few studies have dealt with FNC cryostorage, and even less 
with LN-FNC.74-81 These studies have evaluated the quality and quantity of DNA and RNA 
extraction and subsequent gene expression microarray profiling of different tumors; only a 
limited number of studies has dealt with LN and lymphoproliferative processes.80-84,123,124 
LN-FNC cryostorage can be performed preparing a cell suspension in either 1.0 mL RNA-
later (Applied Biosystems/Ambion, Dallas, Tex) or 0.9 mL of cryopreservation media (80% 
fetal bovine serum [FBS] plus 20% Roswell Park Memorial Institute [RPMI] media 1640; 
Invitrogen, Carlsbad, Calif).  Eppendorfs are then stored at -20°C for DNA and -80°C for 
RNA until they are used. In some studies, cytospins from LN-FNC suspensions were 
stored at -20°C1,91,123 and used for DNA extraction amplification and multiplex sequencing.  
In the study by Ladd et al, one hundred μL of dimethyl sulfoxide (DMSO) were added to 
each cytospin or RMPI, being the needle repeatedly rinsed by aspirating and flushing the 
fluid. Samples were stored for less than 1 month at -20°C and less than 3 days at -4°C be-
fore RNA extraction. The quantity and quality of extracted DNA and RNA has been report-
ed to be satisfying in all the tumor types, but no specific data are available on RNA extrac-
tion from cryostored LN-FNC lymphoproliferative processes. In the study by Peluso et al.83, 
LN-FNC of 80 NHL, 4 Myeloma and 56 BRH were cryopreserved and stored at -80°C. 
DNA extractions were performed, JAK2 gene was amplified to assess the DNA integrity 
and the IGHK/TCRBG clonality status was tested. IGHK monoclonality was found in 99% 
of B-cell NHL and 100% of myeloma. TCRBG monoclonality was found in 100% of T-cell 
NHL. TCRBG polyclonality was detected in 97% of B-cell NHL, 100% of myeloma and 
96% of BRH. IGHK/TCRBG allow assessing cryostorage reliability for subsequent DNA ex-
traction and clonality testing. In a study by Da Cunha et al.123 -20° cryopreserved cytospins 
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from LN-FNC were used for DNA extraction. This study was performed to detect point mu-
tations involving the MYD88, CD79B, and EZH2 genes by a panel specific for HT multiplex 
mutation profiling using a MassARRAY platform (Sequenom, San Diego, CA) and 
Sequenom's assay design tools. All cases with MYD88, EZH2, or CD79B mutations by 
MassARRAY spectrometry were confirmed by PCR followed by direct sequencing. These 
studies confirmed that cryostorage is a perfect support for molecular studies. As far as the 
quantity of nucleic acids is concerned, molecular procedures require a sufficient amount of 
cells and quality genetic material. As previously reported, 10-40 ng of DNA/RNA are gen-
erally sufficient to perform molecular studies. Such amounts are not constant and depend 
on different factors, including the size of the needles, FNC technical procedures and the 
nature of the lesions. It has been calculated that using 23-gauge needles, a mean of 4 × 
106 cells is obtained by LN FNC.80 Considering that 40 ng of DNA/RNA may be obtained 
from 4 × 106 cells, a couple of additional passes from LN FNC may be sufficient to obtain 
genetic material sufficient for any procedure.  
 
FTA cards 
Whatman Classic and Elute FTA cards (Whatman GE, Maidstone, UK) are filter papers 
impregnated with chemicals that lyse cell membranes, mainly uric salt and uric acid that 
denature proteins.127-131 Consequently, residual nucleic acids are framed, immobilized and 
stabilized in the cards by the monovalent weak base of the cards in an alkaline 
environment. FTA cards can be stored at room temperature in shielded re-sealable 
pouches. Therefore, FTA cards protect nucleic acids from nucleases, oxidation, UV 
damage, microbial and fungal attacks and can be used several times by removing small 
pouches from the cards that may directly processed for DNA extraction. FTA cards have 
been used to collect and store genetic material obtained from different procedure and 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
namely by LN-FNC.82,83,124,126 There are 2 main types of cards: the classic FTA card and 
the Elute FTA card, both of which have similar extraction protocols. The advantages of 
such cards include easy storage and simple extraction protocols, making it a valid option 
for research purposes. Residual material from the needle rinse of FNA stored on FTA 
cards yielded sufficient quantities of DNA for successful PCR-based DNA amplification and 
MassARRAY spectrometry.82,83,125,126 Direct PCR using DNA extracted from classic FTA 
cards was successful in 100% of the samples for a 500-base pair amplicon and in 95% of 
the samples for a 1.5-kilobase amplicon, documenting the high-quality DNA retrieved from 
the cards.56Using a predefined MassARRAY panel for B-cell NHL, 99.7% of the cards had 
successful results, a rate that is comparable to that of frozen specimens (100%) and far 
superior to that of CBs, stained smears and cytospin preparations.125,126 In addition, the 
success rate and DNA yield reported was based on material extracted from 2 circle 
punches of the card, each measuring 3 mm, with up to 27 possible punches potentially 
extractable from a fully represented card. Another study showed similar results when 
comparing the DNA extracted from two punches of the cards with that of fresh cell 
suspensions stored at -80°C, using FNC specimens of breast carcinomas. Although the 
quantity of DNA was statistically higher in the frozen material, the purity ratio and DNA 
performance in a PCR-based method was robust and comparable between the two 
preparations.123 The same study highlighted that cards appear to absorb a limited amount 
of cells, which might explain the limited quantity of DNA extracted when compared with 
frozen cell suspensions. Although a morphological assessment of the cards could not be 
performed, an automated cell counter was used to characterize the needle rinse before 
applying the material to the cards and part of the same material was used for generating 
frozen specimens, thereby guaranteeing a comparable analysis. However, the scantier 
genetic material stored on the cards is not an issue when all the advantages of FTA cards 
are considered, including the low cost, high-quality stored material, and the easy handling 
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and transportation.82,83,125,126 With reference to RNA storage and preservation on FTA 
cards, the few available studies obtained discordant results probably due to differences in 
terms of technical procedures and samples. Additional studies of the effect of pre-
analytical variables and different cell concentrations stored on cards are needed to clarify 
remaining issues and to validate this preparation. However, FTA cards are a valid 
alternative to cryostorage mainly in clinical contexts where cryostorage is not available.  
 
SMEARS 
Whereas LN-FNC conventional smears are not the optimal support for ancillary 
techniques, they are often successfully used for different procedures. Air-dried or fixed, 
stained or de-stained conventional smear are a precious source of material and an 
effective support for different ancillary techniques, especially when the diagnosis requires 
tests and procedures which were not foreseen at the time of LN-FNC. This is the case of 
metastases; where alcohol fixed, Papanicolaou-stained smears can be de-stained and 
utilized to test specific antigen by ICC. Some studies have tested HMB45 and S100 for 
melanoma in LN_FNC metastases.90. Whereas there are no standardized procedures for 
this utilization, corresponding experiences have reported good results.26,33,79,90 ICC on de-
stained smear is particularly effective in cases in which it is performed to test few cells that 
are detectable on smears only. ICC on de-stained smears is a predetermined choice in 
case of HL with few diagnostic cells on the smear. In these cases, the identification of 
Hodgkin and Reed Sternberg cells on Papanicolaou stained smears may be exploited to 
test CD30, CD15 and PAX5 on the same cells using the background as negative or 
positive controls (Fig. 6).131 Papanicolaou or May-Grumwald-Giemsa de-stained smears 
have been successfully used for FISH to detect specific translocations.132-135 In these 
cases, de-stained smears combine the advantages of monolayered whole nuclei with the 
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possibility of choosing the most significant part of the smear.  Finally, like in other districts, 
LN-FNC traditional smears are a precious source of DNA used for different tests.63 
 
CONCLUSIONS 
In conclusion this review highlights that, dealing with LN-FNC, different vials and supports 
fit differently with different ancillary techniques. The latter, in turn, perform differently in dif-
ferent pathological processes. Therefore, taking in account their availability in the single 
labs, vials, supports and ancillary techniques for LN-FNC should be chosen and matched 
on the basis of ROSE and clinical indications. Namely, fixed additional smears may be 
used for single ICC determination and are mainly convenient for HL; FC performs the best 
with reactive hyperplasia and low-grade NHL, while CB is very effective on metastases 
and high grade NHL. LBC can be used with almost any LN pathology, provided that suffi-
cient material for basic ICC panel or molecular tests is harvested. As far as cell storage is 
concerned, cryopreservation and FTA cards are the techniques of choice; cryopreserva-
tion is effective both for DNA and RNA, but it requires more supports than FTA cards and it 
is a less practical option. FTA cards, in turn, are easier to handle but less effective to store 
RNA.  
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FIGURE LEGENDS 
Fig.1: Suggested flow chart for the management of cytological material, pre-analytical 
procedures and bio-banking of lymph node cytopathology. 
Fig. 2: Cell-block sections of lymph node metastatic melanoma. a: Hematoxylin-Eosin, b: 
HMB45 immunostaining positivity. 
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Fig. 3: Reactive LN-FNC on cytospin. a: dispersed small lymphocytes, CD3 positive (b); 
CD20 positive in few cells (c). 
Fig. 4: a: Cytological features of a monomorphous low-grade, non-Hodgkin lymphoma. 
Flow cytometry shows CD10/CD19 co-expression (b) and kappa light chain restriction (c). 
Fig. 5: Fig.6  IGH multiplex PCR and sequencing from LN-FNC cells stored at -80° or on 
FTA cards. 
 Fig. 6: a: Suspected Hodgkin lymphoma at ROSE. Additional smears were alcohol-fixed 
and Papanicolaou-stained to check the presence of Hodgkin and Reed-Sternberg cells. 
Smears were then destained and immunostained for CD30 (b) and PAX5 (c). 
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*Limited application, no clinical indications 
 
 
TABLE 1;  main use of the different techniques according to the different lymph node pathologies 
ROSE INDICAT-
ED PATHOLOGY 
Immuno-
cytochemistry 
 
Flow 
Cytometry 
 
FISH
 
Molecular 
 testing 
Cell stor-
ing 
Reactive non 
granulomatous 
None Suspension Smears; Cytospins
 
Smears; Cytospins;  
LBC 
Cytospins
FTA-cards 
Reactive granu-
lomatous 
Smears; Cytospins; 
LBC 
Suspension* None Smears; Cytospins; 
LBC 
Cytospins
FTA-cards 
Small-cell NHL  Cell block; Smears; 
Cytospins; LBC 
Suspension Smears; Cytospins
 
Cell block; Smears; 
Cytospins; LBC 
Cytospins
FTA-cards 
Large-cell NHL Cell block; Smears; 
Cytospins; LBC 
Suspension Smears; Cytospins; 
Cell block 
Cell block; Smears; 
Cytospins; LBC 
Cytospins
FTA-cards 
Hodgkin Lym-
phoma 
Cell block; Smears; 
Cytospins; LBC 
None None Cell block; Smears; 
Cytospins; LBC 
Cytospins
FTA-cards 
Metastasis Cell block; Smears; 
Cytospins; LBC 
Suspension* Cell block; Smears; 
Cytospins 
Cell block; Smears; 
Cytospins; LBC 
Cytospins
FTA-cards 
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